Toward rubella elimination in Europe: an epidemiological assessment.

Authors:
Address: EUVAC.NET hub, Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark. markmuscat1@gmail.com
Journal:

Publication:

abstract

BACKGROUND:

The elimination of rubella and prevention of congenital rubella syndrome (CRS) by 2015 are established goals for Europe. Our aim was to review the epidemiology of rubella in relation to this goal.

MATERIAL AND METHODS:

National surveillance institutions from 32 European countries provided information on rubella and CRS surveillance systems and data for 2000-08. We reported the number of notified rubella cases by year for countries with a national mandatory notification system for rubella covering total country population consistently throughout 2000-08 and analysed rubella surveillance data for 2008.

RESULTS:

Throughout 2000-08, 24 countries conducted passive routine surveillance based on mandatory reporting rubella covering total country population. Altogether these countries reported 526,751 rubella cases. The median incidence per million inhabitants declined from 7.2 in 2000 to 0.3 in 2008. By 2008, the number of countries with mandatory notification systems for rubella increased to 28. These countries reported 21,475 rubella cases of which 1.5% (n=317) were laboratory-confirmed. Most cases (n=21,075; 98%) were reported from Poland, Italy and Romania. Ten countries reported zero rubella cases and five others reported an incidence of <1 per million inhabitants. In 2008, 20 CRS cases were reported from five countries.

CONCLUSION:

The overall decline in rubella incidence and increase in the number of countries conducting rubella surveillance through a mandatory notification system are notable achievements Toward the goal of rubella elimination in Europe. However, in a few countries with high rubella incidence the risk for CRS still exists. Achievement and maintenance of the required high vaccination coverage and high-quality surveillance of rubella and CRS including laboratory testing of all suspected cases are fundamental to eliminate rubella and prevent CRS in Europe.

Related Articles
Modelling the incidence of congenital rubella syndrome in developing countries.
Int J Epidemiol. 1999
Modelling the incidence of congenital rubella syndrome in developing countries.
Cutts FT, Vynnycky E. Int J Epidemiol. 1999 Dec; 28(6):1176-84.
The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention.
JAMA. 2002
The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention.
Reef SE, Frey TK, Theall K, Abernathy E, Burnett CL, Icenogle J, McCauley MM, Wharton M. JAMA. 2002 Jan 23-30; 287(4):464-72.
Measles in Europe: an epidemiological assessment.
Lancet. 2009
Measles in Europe: an epidemiological assessment.
Muscat M, Bang H, Wohlfahrt J, Glismann S, Mølbak K, EUVAC.NET Group. Lancet. 2009 Jan 31; 373(9661):383-9. Epub 2009 Jan 7.
Review Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.
Bull World Health Organ. 1997
Review Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.
Robertson SE, Cutts FT, Samuel R, Diaz-Ortega JL. Bull World Health Organ. 1997; 75(1):69-80.
Review Rubella and congenital rubella syndrome: global update.
Rev Panam Salud Publica. 2003
Review Rubella and congenital rubella syndrome: global update.
Robertson SE, Featherstone DA, Gacic-Dobo M, Hersh BS. Rev Panam Salud Publica. 2003 Nov; 14(5):306-15.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.